Respiratory Cachexia Nutrition Market

Energy-dense low-volume ONS is estimated at 49.5% of formulation demand in 2026 while advanced COPD accounts for 47.1% and RTD represents 42.7%. Adoption depends on nutritional screening and tolerable serving volume, but reimbursement gaps and poor adherence can interrupt repeat use following discharge.